Back to top

Image: Bigstock

Canopy Growth Corporation (CGC) Stock Falls Amid Market Uptick: What Investors Need to Know

Read MoreHide Full Article

The most recent trading session ended with Canopy Growth Corporation (CGC - Free Report) standing at $2.21, reflecting a -0.45% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily gain of 1.83%. On the other hand, the Dow registered a gain of 1.65%, and the technology-centric Nasdaq increased by 2.45%.

Coming into today, shares of the company had lost 27.21% in the past month. In that same time, the Medical sector lost 3.48%, while the S&P 500 lost 3.31%.

The upcoming earnings release of Canopy Growth Corporation will be of great interest to investors. The company is expected to report EPS of -$0.48, up 73.18% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $47.69 million, indicating a 17.31% decrease compared to the same quarter of the previous year.

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$3.31 per share and revenue of $192.31 million, indicating changes of +18.27% and -21.34%, respectively, compared to the previous year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Canopy Growth Corporation. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. As of now, Canopy Growth Corporation holds a Zacks Rank of #3 (Hold).

The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 137, which puts it in the bottom 46% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Canopy Growth Corporation (CGC) - free report >>

Published in